C.E. Credits

The speakers below have been approved for CME, CE, or CEU credits. To redeem your credits, locate the presentation you watched and click on the CME/CE/CEU buttons for further direction. For more general information regarding continuing education, the processes to receive credits, and the accreditation bodies, Click here


MAR 28 - 29 2018

Cannabis Sciences 2018

Our  First Annual Cannabis Sciences virtual conference is now available On Demand! Cannabis Sciences is a growing field of medicine and research, with a regulatory landscape that is ever-changing, as it is becoming more accepted and legalized for medical use and new policies are being developed.

Challenged with navigating the regulatory arena, cannabis research elevates the understanding of metabolic processes to provide innovative treatment options for unmet medical needs. By bringing together cannabis industry experts, instrument manufacturers, testing labs, research scientists, medical practitioners, policy makers and professionals from around the world, LabRoots will drive collaboration and foster innovation from which new ideas expand into integrated solutions.

This complimentary conference offers a fantastic opportunity to benefit from interacting with a global community of like-minded colleagues from the comfort of home. Topics of discussion include analytical testing, extraction, sample prep, edibles manufacturing, regulatory landscape and more. As our first-ever annual event, we aim to further the conversation of cannabis sciences and analytical research.
 

Continuing Education
By participating in this virtual event and watching webcast presentations, you can earn Free Continuing Education (PACE) credits. To earn educational credits, you must view an entire presentation. Following the presentation you must click on the educational credit link provided for that particular speaker and follow the required process. Once you have completed the process, you will receive a certificate for the educational credit.

 

Cannabis Sciences 2018 main topics included:

  • Cannabis Therapies for Diseases
    • Immune Therapy and Stem Cell Therapy
    • Cannabis for Pediatric Disease –
      • Childhood cancer, tumors
      • Autism
      • Guidelines for parents/patients to select a safe medical cannabis product
    • Pain and cannabis impact on opiate use
  • Cannabis Cultivation and Extraction 
    • Cultivating medical cannabis
    • Post-processing of Cannabis: Lab, Pilot and Process Scale
  • Cannabis Testing
    • regulatory compliance and standardization, as they relate to automation and LIMS
    • Cannabis testing and the work RJ Lee Group is doing regarding cannabis lab auditing experience
  • Current Landscape
    • Legal/policy arena
    • Regulatory issues

Quotes from our event attendees:


Use #LRcannabis to follow the conversation


Speakers

Show Resources
You May Also Like
SEP 14, 2016 06:30 AM PDT
C.E. CREDITS
SEP 14, 2016 06:30 AM PDT
An industry leader in delivering instrument systems, reagents, and services to life science researchers,Beckman Coulter Life Sciences helps enable new discoveries in biology-based research...
NOV 02, 2016 06:00 AM PDT
C.E. CREDITS
NOV 02, 2016 06:00 AM PDT
The 7th annual Clinical Diagnostics & Research conference is now On Demand!  This premiere venue discusses the latest advances in clinical diagnostics, research and medicine. The con...
NOV 08, 2017 06:00 AM PST
C.E. CREDITS
NOV 08, 2017 06:00 AM PST
LabRoots invites you to the 8th annual Clinical Diagnostics & Research free online conference! Clinical diagnostics is an ever-changing field of medicine and research, challenged wit...
MAY 28, 2014 06:00 AM PDT
C.E. CREDITS
MAY 28, 2014 06:00 AM PDT
This year will be our 5th annual Clinical Diagnostics & Research online conference. Attendees can earn free CME and CE Credits. The theme of this conference is a range of medical and clin...
MAR 19, 2014 06:00 AM PDT
C.E. CREDITS
MAR 19, 2014 06:00 AM PDT
BioConference Live makes it easier and more cost-effective for the neuroscience research community to come together online through live video webcasts and real-time networking. BioConference...
NOV 11, 2015 06:00 AM PST
C.E. CREDITS
NOV 11, 2015 06:00 AM PST
Welcome to LabRoots’ 6th Annual Clinical Diagnostics & Research free online conference! The event is now available on-demand and you can attend sessions including keynotes...
Agenda
  • MAR 28, 2018 06:00 AM PDT
    Speaker: Kent Crowley, Pharm. D., FAARFM
  • MAR 28, 2018 06:00 AM PDT
    Speaker: Jahan Marcu, PhD, PFC
  • MAR 28, 2018 07:30 AM PDT
    Speaker: Jeff Hergenrather, MD
  • MAR 28, 2018 09:00 AM PDT
    Speaker: Markus Roggen, PhD
  • MAR 28, 2018 09:00 AM PDT
    Speaker: Emily Leongini
  • MAR 28, 2018 09:00 AM PDT
    Speaker: Shawn Kassner
  • MAR 28, 2018 10:30 AM PDT
    Speaker: Catharine Layton
  • MAR 28, 2018 10:30 AM PDT
    Kent Crowley, Pharm. D., FAARFM
    Director of Research & Product Development, Silver Stat...
    Sebastien Cotte
    Director and Board Member for the Flowering Hope Founda...
    Janie Maedler
    CEO & Co-Founder, Rylie's Sunshine
    Herah Osborne
    Advocacy Founder, Strainz
  • MAR 28, 2018 12:00 PM PDT
    Speaker: Lalit Chordia, PhD
  • MAR 28, 2018 12:00 PM PDT
    Speaker: James Eaves, PhD
  • MAR 28, 2018 01:30 PM PDT
    Speaker: Jeffrey Matura
  • MAR 28, 2018 01:30 PM PDT
    Speaker: Christine Paszko, PhD, MT (ASCP)
  • MAR 29, 2018 06:00 AM PDT
    Speaker: Jeffrey Dahl, PhD
  • MAR 29, 2018 06:00 AM PDT
    Speaker: Paul Mavor, Pharm. D
  • MAR 29, 2018 06:00 AM PDT
    Speaker: Sebastien Cotte
  • MAR 29, 2018 07:30 AM PDT
    Speaker: Russ Cersosimo Jr.
  • MAR 29, 2018 09:00 AM PDT
    Speaker: Robert Morgan
  • MAR 29, 2018 09:00 AM PDT
    Speaker: Katherine Stenerson
  • MAR 29, 2018 09:00 AM PDT
    Speaker: Debra Kimless, MD
  • MAR 29, 2018 10:30 AM PDT
    Speaker: Jason Lupoi, PhD
  • MAR 29, 2018 10:30 AM PDT
    Speaker: Fritz Chess
  • MAR 29, 2018 10:30 AM PDT
    Speaker: Janie Maedler
  • MAR 29, 2018 12:00 PM PDT
    Speaker: Rick Jordan
    Sponsored By: Agilent
  • MAR 29, 2018 12:00 PM PDT
    Speaker: Judy Mikovits, PhD
  • MAR 29, 2018 01:30 PM PDT
    Speaker: Joshua Kaplan, PhD
  • MAR 29, 2018 01:30 PM PDT
    Speaker: Donald Land, PhD
  • Cannabis Therapies for Diseases
  • MAR 28, 2018 06:00 AM PDT
    Speaker: Kent Crowley, Pharm. D., FAARFM
  • MAR 28, 2018 07:30 AM PDT
    Speaker: Jeff Hergenrather, MD
  • MAR 28, 2018 10:30 AM PDT
    Kent Crowley, Pharm. D., FAARFM
    Director of Research & Product Development, Silver Stat...
    Sebastien Cotte
    Director and Board Member for the Flowering Hope Founda...
    Janie Maedler
    CEO & Co-Founder, Rylie's Sunshine
    Herah Osborne
    Advocacy Founder, Strainz
  • MAR 29, 2018 06:00 AM PDT
    Speaker: Sebastien Cotte
  • MAR 29, 2018 09:00 AM PDT
    Speaker: Debra Kimless, MD
  • MAR 29, 2018 10:30 AM PDT
    Speaker: Janie Maedler
  • MAR 29, 2018 12:00 PM PDT
    Speaker: Judy Mikovits, PhD
  • MAR 29, 2018 01:30 PM PDT
    Speaker: Joshua Kaplan, PhD
  • Cannabis Cultivation and Extraction
  • MAR 28, 2018 06:00 AM PDT
    Speaker: Jahan Marcu, PhD, PFC
  • MAR 28, 2018 09:00 AM PDT
    Speaker: Markus Roggen, PhD
  • MAR 28, 2018 12:00 PM PDT
    Speaker: Lalit Chordia, PhD
  • MAR 29, 2018 09:00 AM PDT
    Speaker: Katherine Stenerson
  • MAR 29, 2018 10:30 AM PDT
    Speaker: Fritz Chess
  • Current Landscape
  • MAR 28, 2018 09:00 AM PDT
    Speaker: Emily Leongini
  • MAR 28, 2018 12:00 PM PDT
    Speaker: James Eaves, PhD
  • MAR 28, 2018 01:30 PM PDT
    Speaker: Jeffrey Matura
  • MAR 29, 2018 06:00 AM PDT
    Speaker: Paul Mavor, Pharm. D
  • MAR 29, 2018 10:30 AM PDT
    Speaker: Jason Lupoi, PhD
  • Cannabis Testing
  • MAR 28, 2018 09:00 AM PDT
    Speaker: Shawn Kassner
  • MAR 28, 2018 10:30 AM PDT
    Speaker: Catharine Layton
  • MAR 28, 2018 01:30 PM PDT
    Speaker: Christine Paszko, PhD, MT (ASCP)
  • MAR 29, 2018 06:00 AM PDT
    Speaker: Jeffrey Dahl, PhD
  • MAR 29, 2018 07:30 AM PDT
    Speaker: Russ Cersosimo Jr.
  • MAR 29, 2018 09:00 AM PDT
    Speaker: Robert Morgan
  • MAR 29, 2018 12:00 PM PDT
    Speaker: Rick Jordan
    Sponsored By: Agilent
  • MAR 29, 2018 01:30 PM PDT
    Speaker: Donald Land, PhD
Speakers

  • Russ Cersosimo Jr.
    Founder, Medical Cannabis Society and CEO, Miradati Technology
    Biography
      Russell Cersosimo Jr. is the founder of Pittsburgh-based Miradati Technology, which is currently developing HIPAA-compliant, enterprise software that creates standardized data for medical cannabis research. Integrating both legacy and proprietary technologies, Miradati helps facilitate this rapidly developing field of study, producing quantifiable data that more accurately measures patient outcomes, reduces prescribing errors, and lowers patient costs. In 2015, Russ founded the Pennsylvania Medical Cannabis Society (PAMCS), the Commonwealth of Pennsylvania's largest organization for professionals, educators and leaders in the industry. Since its inception, PAMCS has been involved in over 45 educational events throughout the Commonwealth of Pennsylvania. PAMCS and Cersosimo's advocacy efforts were instrumental in 2016's successful legalization campaign. Today, Cersosimo is committed to forging partnerships that improve the capture and analysis of medical cannabis data. Russ sits on the ASTM D37 committee for writing cannabis industry standards and is passionate about developing solutions that will shape the industry. The Pennsylvania Medical Cannabis Society has converted to a national model and has launched Medical Cannabis Society chapters in West Virginia - with plans to open in Maryland, Michigan, and New Jersey in 2018. A serial entrepreneur as far back as his days studying Psychology at West Virginia University, Cersosimo founded Webbula, a data-centric technology company. As its CEO, Cersosimo generated high-profile clientele including Google, Yahoo, T-Mobile, Neustar, and Epsilon. Mr. Cersosimo also serves as CEO for marketing firm Optimal Reach Media. He currently sits on the Board of Directors of the Tourettes Syndrome Awareness Foundation.
    • Jeff Hergenrather, MD
      Consultation physician, President of the Society of Cannabis Clinicians, Vice President of the American Academy of Cannabinoid Medicine (AACM), Northern California
      Biography
        Jeff Hergenrather is a general practitioner specializing in cannabis/cannabinoid medicine since 1999. His medial experience includes 26 years in emergency medicine and private general practice that includes the medical use of cannabis since 1977. He continues in a consultation practice in northern California with face-to-face, telephone, and on-line consultations for the use of cannabis as medicine. Dr. Hergenrather's practice, research, and teaching focus on the medicinal use of cannabis through a wide range of conditions and age groups - from infants to elder care. He is teaching a Biology course in the Medical Use of Cannabis at Sonoma State University. He is a founding member and current president of the Society of Cannabis Clinicians, a non-profit corporation dedicated to quality patient care, education, and clinical studies. He is a member of the International Cannabinoid Research Society (ICRS) and the International Association for Cannabinoids in Medicine (IACM). He also serves as an expert witness and consultant to local government and industry in supporting safe access to measured cannabis medicines.
      • Fritz Chess
        Founder and Chief Scientist at Eden Labs
        Biography
          Eden Labs evolved from Fritz's research about remote indigenous peoples using botanicals to cure illness. Early findings ignited a spark to unlock more secrets of botanicals using extraction and distillation. Curiosity became dedication as he pursued finding and producing more healthful, natural products for human health and consumption. Fritz began extraction disruption with the redesign of the century old soxhlet extractor, creating Eden Labs' trademark Coldfinger™ line. Experimentation continued-exploring the use of solvents, pressures, and temperatures-leading to Eden Labs' first Supercritical CO2 extraction machine, specifically engineered for small business, which Eden still serves but has organically expanded to include industrial plants. His breakthroughs provided purity and efficiency for start-ups and R&D in multiple industries, including nutraceuticals, functional foods, hemp, etc. Fritz's passion makes Eden Labs a trusted partner for those entering the new field of extraction and distillation of cannabis and other botanicals for the health of the world.
        • Lalit Chordia, PhD
          President and CEO, Thar Energy, LLC
          Biography
            For the last 30 years, Dr. Chordia has pioneered R&D in and commercial applications of supercritical fluid technology, a green materials processing technology. While earning his doctorate in 1982, Dr. Chordia co-founded his first company, Suprex Corp, and then served as Vice President of Engineering and R&D. Suprex was the first company to focus only on supercritical fluids. Dr. Chordia left Suprex in 1990 and formed Thar Technologies. Through his technological and commercial leadership, Dr. Chordia has taken Thar from one employee to a global leader in its field. This transformation has led to the creation of several spin offs, including: 1) Thar Instruments, which in 2009 was sold to the Waters Corporation, a publicly-traded world leader in scientific instrumentation; 2) Thar Pharmaceuticals, a drug development company; 3) Thar Process, a designer and marketer of process scale supercritical fluid technology; 4) Thar Energy, a developer of alternative, green energy technology such as advanced biofuels; and 5) Thar Geothermal, a developer of high-efficiency, green heating and cooling technologies. Some examples of Thar's involvement in supercritical fluid process and equipment technologies over the years are natural pharmaceutical and spice extraction, drug purification and design, coatings, electronics cleaning, cooling, advanced biofuels and a host of other applications and equipment technologies. In particular, extraction of cannabis and the separation of individual cannabinoid for large scale production. Thar's facility in Pittsburgh includes the largest high pressure toll processing facility in the world and Thar has built the largest high pressure SFC equipment in the world. Recognizing his accomplishments, the United States Small Business Administration named Dr. Chordia the 2002 US Small Business National Exporter of the Year, an award he won in a competition against all companies nationwide with up to 500 employees. Dr. Chordia has also been the primary investigator on multiple research and development projects, including two prestigious Advanced Technology Program awards through the National Institute of Standards and Technology. In 2010, Dr. Chordia was honored with the Distinguished Alumnus Award of IIT Madras, the Carnegie Science Entrepreneur Award and in 2015, elected a Fellow by The American Association for the Advancement of Science (AAAS) and in 2017 received the regional EY (Ernst & Young) Entrepreneur of the Year. Dr. Lalit Chordia received his bachelor's degree in chemical engineering from the Indian Institute of Technology, and earned a doctorate in chemical engineering from Carnegie Mellon University (Pittsburgh, PA).
          • Sebastien Cotte
            Director and Board Member for the Flowering Hope Foundation
            Biography
              Sebastien Cotte became actively involved in the field of medical marijuana in 2013 while seeking alternative treatments for his son Jagger's, rare terminal Mitochondrial disease. In 2014, with his wife Annett, they became medical refugees in Colorado to access cannabis oil for Jagger. They lived in Colorado for 13 months before moving back to Georgia. Sebastien received a bachelor degree in international business from the University of Indianapolis and has over 15 years of business experience at several Fortune 500 companies. His areas of expertise include: human resources, training, process improvements, sales management, customer care, marketing, brand building, etc. Sebastien also completed a Medical Marijuana certification program offered by Americans for Safe Access and is in the process of finishing a few more industry certifications. He serves as an ambassador for the United Mitochondrial Disease Foundation and is one of the co-founder of Georgia's Hope, the leadership parent group that was successful in getting a Medical Cannabis law passed in Georgia. (HB1 Haleigh's Hope). Sebastien is the national business/education director and a board member for the Flowering Hope Foundation (a 501c no for profit that provides education and patient support for Haleigh's Hope-Cannatol products). He is also on the board of advisor of MDherb, a cannabis education website, the Georgia action group leader for Americans with Safe Access and the VP of the "Talk to the 6630507 hand" campaign which aim at de-scheduling cannabis.
            • Kent Crowley, Pharm. D., FAARFM
              Director of Research & Product Development, Silver State Trading
              Biography
                Kent Crowley, Pharm.D., is a board-certified Pharm.D. through the American Academy of Anti-Aging Medicine. He received his Doctor of Pharmacy from University of California, San Francisco and completed his residency with Kaiser Permanente in Los Angeles, CA. He completed his Fellowship in Metabolic and Nutritional Medicine in 2011. During his 34 years in practice, he has worked in primary research at UCI, Dept. of Pediatrics, Division of Child Development, involved in the development of several drugs; holds two patents in neuropathic pain and a patent on a buccal delivery system incorporating cannabis. Dr. Crowley currently is the Director of R&D at Silver State Trading in Sparks, NV, a 40,000 sq.ft. permitted Clean Green cannabis cultivation and production facility. He serves as the CMO for the Palliative Care Corporation in Huntington Beach, CA, working with patients & physicians incorporating cannabis in disease state treatment and symptoms management, whether as a primary treatment or complementary to traditional and/or other modalities. This same approach is practiced through Bud and Bloom in Santa Ana, CA as a clinic day each week for patients to come to a Best in Class dispensary and get good information/education on cannabis products/dosage forms/routes of administration and incorporate that into a functional medicine consult for personalized treatment goals. Dr. Crowley is a member of the Society of Cannabis Clinicians and serves on the Research Subcommittee and a member of the International Cannabinoid Research Society.
              • Jeffrey Dahl, PhD
                Applications Scientist at Shimadzu
                Biography
                  Jeff Dahl is an application scientist with Shimadzu, and specializes in Mass Spectrometry. Jeff received his Ph.D. in Medicinal Chemistry at the University of Illinois at Chicago in 2010. His research, among other things, includes small molecule quantitation, pesticides and other chemical residues, cannabis analysis, and metabolomics using high resolution MS.
                • James Eaves, PhD
                  Professor, Université Laval
                  Biography
                    James Eaves received his Ph.D in Agricultural Economics from the University of California, Davis. Today, he is a management professor at Université Laval, where he is part of a research group that aims to find ways to increase the profitability of growing cannabis indoors and in greenhouses. He is a regular invited speaker at cannabis conferences across North America, writes for Canada's leading cannabis trade journal, and his award winning research has been discussed in numerous media outlets, including The Washington Post, Newsweek, and the CBC.
                  • Rick Jordan
                    Laboratory Manager, Pacific Agricultural Laboratory
                    Biography
                      Rick Jordan is the Laboratory Manager for Pacific Agricultural Laboratory (PAL), in Sherwood, OR. After receiving his B.Sc in Physics from Washington State University in 1989 he spent 11 years as an environmental chemist specializing in organic compounds using both gas and liquid chromatography. Since joining PAL in 2001, Rick has focused on pesticide residue analysis and method development. PAL is an ISO 17025:2005 accredited laboratory with a broad range of sample types raging from fruits and vegetables to dried hops and herbal extracts. Rick has been an active participant in the North American Chemical Residue Workshop as an attendee and presenter since 2009. He has co-authored numerous publications, application notes, and posters related to the analysis of pesticide residues. He is involved in method development for both target residue analysis and large comprehensive screening methods.
                    • Joshua Kaplan, PhD
                      Senior Fellow, Department of Pharmacology, University of Washington
                      Biography
                        Dr. Josh Kaplan, Ph.D., is a senior fellow in the Department of Pharmacology at the University of Washington. He earned his Ph.D. in Behavioral Neuroscience at Oregon Health & Science University in 2015 studying the neural mechanisms underlying risk for developing alcohol use disorders, after which he moved north to Seattle where he researches the therapeutic potential of cannabis and the endocannabinoid system. Dr. Kaplan uses behavioral neuroscience and neurophysiology to better understand the therapeutic efficacy of cannabis as well as it's neural mechanism.
                      • Shawn Kassner
                        Senior Scientist at Neptune and Company, Inc.
                        Biography
                          Mr. Kassner is a Senior Scientist with Neptune and Company, Inc. with a wide range of interests in environmental science. He has 27 years of experience in the environmental community, 8 years performing GC/MS volatile and semi-volatile analysis, as well as being a group leader for GC/MS analytical and preparatory groups in environmental and mixed waste laboratories. Mr. Kassner spent 19 years involved in proficiency testing for federal, state, municipal and private environmental laboratories for drinking water, waste water and soil methodologies. Mr. Kassner has been involved in the formation of national standards for laboratory accreditation and has been an active leader in the The NELAC Institute. Mr. Kassner earned his Bachelor of Science in Biology at the Metropolitan State University of Denver.
                        • Debra Kimless, MD
                          Medical Director, ForwardGro
                          Biography
                            Debra Kimless, M.D. graduated magna cum laude, Phi Beta Kappa from Muhlenberg College with a double major in Natural Sciences and Biology. She attended medical school at Rutgers, and residency at Temple University Hospital and is a boarded Anesthesiologist with a subspecialty certification in Pain Medicine. Motivated by her mother who suffered with intractable pain at the end of her life and responded paradoxically to opiates, Dr. Kimless became a passionate champion for medical cannabis. Dr. Kimless traveled the world studying under the most respected experts in cannabis medicine and research. In addition to being the Medical Director of ForwardGro a medical cannabis cultivation company in Maryland, Dr. Kimless teaches the endocannabinoid system and how medical cannabis can be an effective therapeutic tool. She consults with patients, pro bono and collects patient data and presents the cases at national and international conferences and seminars. Her passion is to use education to de-stigmatize cannabis and explain how it may be used as an effective medical therapeutic choice.
                          • Donald Land, PhD
                            Chief Scientific Consultant, Steep Hill Labs, Inc.
                            Biography
                              As Chief Scientific Consultant, Dr. Land guides the Science and Product Development groups at Steep Hill. His role includes optimizing scientific processes in the business, developing best practices, and evaluating new business opportunities from a scientific perspective. Dr. Land co-founded Halent Laboratory in 2010, which was then a major competitor to Steep Hill, later merging Halent into Steep Hill in 2013, to unite the two leading cannabis science firms. Dr. Land is a nationally recognized scientific expert on the chemistry of the cannabis plant and is in great demand as an educational speaker on its effects. Dr. Land is also a currently tenured professor at UC Davis where his research spans the fields of Forensic Science, Biotechnology and Sensor Development. Dr. Land is a member of the UC Davis Forensic Science Graduate Group and the Designated Emphasis in Biotechnology, in addition to his continuing position in Chemistry. At UC Davis, he developed a program in interfacial analytical chemistry and a wide-ranging program in forensic chemistry. Dr. Land received a PhD from the University of California, Irvine where he developed novel techniques using laser-induced thermal desorption with Fourier transform mass spectrometry, along with electron and ion spectroscopies. His work at UC Irvine earned him an IBM Corporation Graduate Research Fellowship, as well as a prestigious Alexander von Humboldt Fellowship to conduct postdoctoral research in surface vibrational spectroscopy at the KFA Researchzentrum in Jülich, Germany. Dr. Land was subsequently hired as an Assistant Professor in the Department of Chemistry at the University of California, Davis in 1991, at just 28 years of age.
                            • Catharine Layton
                              Senior Technical Application Chemist at Waters Corporation
                              Biography
                                Catharine is a Senior Technical Applications Chemist at Waters Corporation in Milford, MA where she works closely with technical experts in chromatographic purification, supercritical fluid separation, and bio-botanical extraction. Catharine received undergraduate degrees in Biological Science and Chemistry at the University of North Carolina at Chapel Hill and her Master's degree at Western Connecticut State University. She began her career in Biopharmaceutical Research and Development at a fast-paced, international contract research organization and drug development laboratory where she was responsible for the design of analytical methods used to characterize novel biological therapeutics formulated by key research organizations. Catharine later moved into large pharma where she dedicated over 15 years to the development of analytical methods and implementation of testing strategies for drug delivery devices and complex small molecule formulations while working in both the United States and Europe. She is most recently the author of "The Beginners Guide to Preparative Liquid Chromatography".
                              • Emily Leongini
                                Attorney, Arent Fox LLP
                                Biography
                                  Emily is member of the FDA practice group in Arent Fox LLP's Washington D.C. office. Arent Fox is a D.C.-based internationally recognized law firm that provides strategic counsel to clients that range from Fortune 500 corporations and start-ups, to trade associations and foreign governments. Emily focuses her practice on a variety of highly-regulated products including prescription and over-the-counter drugs, dietary supplements, foods, and cannabis. She routinely counsels clients on issues that affect the cannabis industry, such as licensing and permitting requirements, labeling and promotional review, good manufacturing and distribution practices, and supply chain management. Before joining Arent Fox, Emily worked at the U.S. Food and Drug Administration for nearly six years. She has followed the legalized cannabis industry since 2004, while during graduate school, she worked with a major county health department to implement the requirements of California's Medical Marijuana Identification Card Program (SB 420). Emily also speaks and writes regularly on current regulatory issues facing the cannabis industry. She earned a JD from American University, Washington College of Law, a Master of Public Policy from the University of Southern California, and BA from the University of Texas at Austin.
                                • Jason Lupoi, PhD
                                  Consulting Scientist/Analytical Chemist, RJ Lee Group, Inc.
                                  Biography
                                    Dr. Lupoi graduated summa cum laude from a small school in Pittsburgh, Pennsylvania, with a B.S. in Chemistry, prior to attending graduate school at Iowa State University. There, Dr. Lupoi began his interest in evaluating plants with different analytical tools, such as spectroscopy, a line of research that continued in two postdoctoral appointments for the University of Queensland/Lawrence Berkeley National Lab and the National Renewable Energy Lab. Before coming to RJ Lee Group, Dr. Lupoi led research projects predominantly focused on the creation of multivariate analysis data models. These models were developed using vibrational spectroscopy coupled with reference methods, such as chromatography that enabled the use of high-throughput spectroscopic instrumentation for the rapid screening of a diverse array of plants, including cannabis. At RJ Lee Group, Dr. Lupoi serves as a technical expert for the auditing and approving of WSLCB cannabis testing laboratories in support of I502. Dr. Lupoi's other work includes: the creation of a novel infrared imaging method that compared wild-type and modified sugarcane for localizing polyhydroxybutyrate expressed in sugarcane and a technique for immobilizing cellulase to silica nanoparticles for use in simultaneous saccharification and fermentation reactions that led to a two-fold increase in ethanol concentration. Dr. Lupoi has authored several peer-reviewed manuscripts, review articles, and a book chapter, has been an associate editor of a Special Topic journal in Frontiers in Biotechnology and Bioengineering, and has been a reviewer for several leading biofuel and analytical chemistry journals.
                                  • Janie Maedler
                                    CEO & Co-Founder, Rylie's Sunshine
                                    Biography
                                      Janie and her family's life was forever changed in 2013, after noticing changes to her daughter, Rylie's face a tumor was discovered aggressively eating away the left side of her face and palate. After hearing this devastating news Janie dove into research. She could not deny giving Rylie the best outcome if it was a possibility. After seeing remarkable results Janie single handedly fought for Delaware to have a pediatric medical marijuana law and for it's pediatric medical card holders to be allowed to have their cannabis oil on school property. Both of these laws, Rylie's Law in 2015 and SB181 in 2016, passed with unanimous votes which is unprecedented. In 2017, Janie was able to reignite HB210 that had stalled in the House in the very last week of the legislation, a Bill that would change the process of how Qualifying Conditions are added to regulations for pediatrics, and it passed successfully in the last hours of session. Following this legislative change, Janie submitted a petition to add Pediatric Autism as a Qualifying Condition to Rylie's Law. Janie continues to this day to stay extremely active as a policy advisor, speaker, educator and consultant in pediatric medical cannabis in the hopes of giving families better options they may not have had before. The family's amazing story and advocacy work has been featured on many numerous News Channels, Talk Shows, The Medical Cannabis Report, Beach Life Magazine, CannaHealth, and CannaTech. Janie's daughter, Rylie, has followed in her foot steps by creating her own 501(c)3 at the age of 9, Rylie's Smile foundation, which helps children with life threatening illnesses escape from their realities to relieve stress in the hospital, contributes to pediatric medical research and advocates for alternative therapies.
                                    • Jahan Marcu, PhD, PFC
                                      Director and Chief Scientific Officer, Americans For Safe Access
                                      Biography
                                        Jahan Marcu, Ph.D., is currently the Chief Science Officer at Americans for Safe Access (a medical cannabis patient advocacy non-profit) and Director of the Patient Focused Certification program, which is a health and safety oversight program that assesses regulatory compliance at cannabis operations. He is co-founder of the International Research Center on Cannabis and Mental Health and is on the scientific advisory board of the International Cannabis and Cannabinoid Institute (Czech Republic). He is also co-founder and past-chairman of the CANN subdivision of the Chemical Health and Safety Division (DCHAS) of the American Chemical Society. His is also on the Board of Directors of the International Association for Cannabinoids as Medicine (Germany). He has a background in analytical chemistry and molecular pharmacology, he received his Ph.D. for contributions in characterizing the structure and function of the cannabinoid receptors. He is an author of the American Herbal Pharmacopeia's Cannabis Monograph and serves on multiple expert government, trade association committees, scientific organizations and is a court-qualified synthetic cannabinoid and cannabis expert. He has helped create the first standards for the medical cannabis industry with the American Herbal Products Association, as well as related educational training for clinicians and workers in the industry. He has been invited to speak at many international conferences, universities, hospitals, including the University of Leiden, Temple University School of Medicine, Princeton Hospital, and Yale University. Dr. Marcu is a recipient of the Billy Martin research award from the International Cannabinoid Research Society.
                                      • Jeffrey Matura
                                        Attorney, Barrett & Matura, P.C.
                                        Biography
                                          Jeff Matura is a founding shareholder of Graif Barrett & Matura, P.C. His practice emphasizes commercial litigation, municipal and governmental law, and insurance law. He is AV-Rated by Martindale-Hubbell, which is the highest peer-review rating an individual lawyer can receive. He has also received the Rising Stars designation by Super Lawyers. In his commercial litigation practice, Mr. Matura represents private and public companies in a variety of matters, including contract disputes, fraud claims, employment issues, insurance disputes, and other business-related issues. Mr. Matura works closely with in-house counsel on all business matters, and often serves as the first person to call when a company lacks its own established in-house legal department. Mr. Matura is also the head of the firm's medical cannabis and marijuana law practice group. In this capacity, he advises dispensaries, cultivation facilities, and other licensed entities and individuals regarding compliance with the Arizona Medical Marijuana Act. He also provides counseling regarding corporate structures, contracts, policies and procedures, and licensing issues that arise with the growing, production, and sale of medical cannabis. When disputes arise, Mr. Matura handles litigation matters involving all aspects of medical cannabis, including disputes against the Arizona Department of Health Services. In his municipal and governmental law practice, Mr. Matura represents towns, cities, and counties throughout Arizona. Mr. Matura defends these municipalities against civil rights claims, employment disputes, housing matters, police enforcement issues, and other contested actions. Mr. Matura serves as the town or city attorney for several municipalities, works closely with a Town or City Manager, and often appears before a Town or City Council to provide advice on pending matters and updates on important laws. Mr. Matura also has specialized knowledge and experience regarding the Civil Rights Act, the Arizona and Federal Fair Housing Acts, reasonable accommodation requests, law enforcement disputes, and public records requests. Mr. Matura also testifies before the Arizona State Legislature to provide input on behalf of clients on proposed legislation that could impact municipalities. In his insurance law practice, Mr. Matura represents international and national life insurance companies, property and casualty companies, and other insurers. He often represents these insurers against first-party breach of contract and bad faith lawsuits, analyzes claims and medical payment issues, and advises insurers on their business needs and compliance with Arizona insurance laws. Mr. Matura handles disputes from their inception and through trial. He has completed numerous jury trials in federal and state courts. He has also completed more than 50 administrative trials before various regulatory and administrative bodies throughout Arizona.
                                        • Paul Mavor, Pharm. D
                                          Pharmacist, Medical Cannabis Research Australia
                                          Biography
                                            Paul is a pharmacist who has been researching the potential of medicinal cannabis as a treatment for several years. His company was granted the first medicinal cannabis import license in Australia and he is currently distributing medicinal cannabis products to eligible patients. Paul brings a wealth of knowledge from his hands-on research in the U.S., Canada and Israel. www.healthhouse.com.au
                                          • Judy Mikovits, PhD
                                            Founder/Consultant at M.A.R.C. INC and Director of Cancer Biology at EpiGenX Pharmaceuticals
                                            Biography
                                              Dr. Judy A. Mikovits earned a BA in Chemistry with a specialization in biology from the University of Virginia in 1980 and a PhD in biochemistry and molecular biology from George Washington University in 1992. ​ Upon graduation from UVA, she went directly to the National Cancer Institute in Frederick Maryland where she developed purification methods for Interferon alpha. It was this Interferon which was used in the first immune therapy treatment for hairy cell leukemia in 1986. In 1986-7, prior to enrolling in graduate school. she went to Upjohn Pharmaceuticals in Kalamazoo Michigan to develop production methods to insure biological materials manufactured using human blood products were free of contamination from HIV-1. Her PhD thesis defense entitled "Negative Regulation of HIV Expression in Monocytes" changed the paradigm for therapeutic treatment of HIV. For this work, she was awarded the graduate student of the year in 1991. In her thirty-five-year quest to understand and develop therapies for chronic diseases, she has co-authored seminal papers culminating at least a decade of research in each of four fields: immunology, natural products chemistry, epigenetics, and HIV/AIDs drug development. In 2006, Dr. Mikovits became attracted to the plight of families with neuroimmune diseases including ME/CFS and Autism and was primarily responsible for demonstrating the relationship between environmentally acquired immune dysfunction, chronic inflammation and these diseases. Her pioneering work during a twenty year career at the National Cancer Institute includes the discovery of the modulation of DNA Methylation machinery by human retro viral infection and the development of the concept of inflammatory cytokines and chemokine signatures of infection and disease, which was first published in 1999, when Dr. Mikovits directed the Laboratory of Antiviral Drug Mechanisms in developing therapeutics and diagnostics for HIV/AIDS and AIDS associated malignancies. Therapies which are still standard of care twenty five years later and credited with saving millions of deaths from HIV/AIDS. In 2001, she moved back to industry where she directed the Cancer Biology program of EpiGenX Pharmaceuticals. The company focused on the development multiplex diagnostic epigenetic and proteomics expression technologies for the prediction of Immune Related Adverse Events to chemotherapy in susceptible populations. In 2006 she co-founded and developed the first neuroimmune research institute dedicated to understanding the pathophysiology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and related illnesses. In five short years, she won more than 6 million dollars of NIH/DOD competitive funding in grants and contracts for this program. In 2009, Drs. Ruscetti and Mikovits' labs isolated for the first time a new family of human retroviruses then identified as XMRV. In 2012 it was learned XMRV was a contaminant of the Silverman lab and the XMRVs isolated were a new human exogenous and transmissible retrovirus family, which are strongly associated with neuroimmune disease and cancer. This new family of pathogenic human retroviruses is now called HGRV. Dr. Mikovits has co-authored more than 50 peer reviewed publications and book chapters and the book Plague.
                                            • Robert Morgan
                                              Director Technical Committee Operations, ASTM International
                                              Biography
                                                Bob is a graduate of Shippensburg University with a BS in Geoenvironmental Science. Bob has spent his 35 year career working for ASTM International. ASTM International was created in 1898 as a solutions provider and a developer of consensus standards for multiple industries affecting aviation fuel, construction materials, medical devices and consumer products, to name a few.. ASTM's mission is directed at the quality of products and services and the health and safety of the consumer and the environment for 90 different industry sectors. During his career, he has worked with dozens of industries, facilitating stakeholder engagement with the development of voluntary consensus standards. His most recent assignment has been working with the Cannabis industry. ASTM Committee D37 on Cannabis was created in 2017 and currently has 280 members representing production facilities, laboratories, State and Provincial Regulators, and consumers.
                                              • Herah Osborne
                                                Advocacy Founder, Strainz
                                                Biography
                                                  Herah is the mother to twins with Fragile X syndrome that has used cannabis to treat and improve the quality of life for her children. She discovered the need to create a reliable cannabis product line and was one of the Original partners of Strainz NV, now in multiple states. She is the Regional Account Manager for Silver State Trading and she is an advocate and speaker regarding the use of cannabis in autism.
                                                • Christine Paszko, PhD, MT (ASCP)
                                                  Vice President, Sales & Marketing Accelerated Technology Laboratories, Inc.
                                                  Biography
                                                    Dr. Paszko is an innovative, customer-centric leader with strong communication skills and the ability to collaborate well with both sales and technical teams. A strong leader with a commitment to driving growth in the rapidly evolving technology industry. Her unique career combines a Ph.D. in infectious disease and Microbiology with 20+ years of experience in defining and directing marketing and sales and business development strategies. This approach has helped customers to outperform competitors with best in class Laboratory Information Management Systems, Positive ID, and Automation Technology. Dr. Paszko's multicultural background provides a real-world understanding of the importance of sales leadership and relationship management to the bottom line.
                                                  • Markus Roggen, PhD
                                                    VP Extraction, OutCo
                                                    Biography
                                                      Markus brings an outside perspective, founded on a solid scientific base, to the cannabis field. An organic chemist by training, Markus took the plunge into the cannabis world by establishing a testing laboratory. He also built an extraction facility for large volume supercritical CO2 extraction. Markus is deeply interested in the molecular properties of the plant, including testing, extracting, and the transformation of active ingredients. As a strong proponent of basic research, Markus constantly tests the limits of current cannabis science and is always willing to help others with their research. Born in Germany, Markus took a very international route in the pursuit of his chemistry doctorate. His various stops around the globe include undergraduate studies at Imperial College, London, research stays in Germany and Singapore, a Ph.D. at ETHZ in Switzerland, and, finally, postdoctoral studies at The Scripps Research Institute in San Diego.
                                                    • Katherine Stenerson
                                                      Principal Scientist, MilliporeSigma
                                                      Biography
                                                        Kathy Stenerson is a Principal Scientist in Workflow Development, at the life science business of Merck KGaA, Darmstadt, Germany, which operates as MilliporeSigma in the U.S. and Canada. Her current work involves developing workflow solutions for extraction and analysis to address problems related to analytical testing, with a focus on the areas of food & beverage, environmental and cannabis testing. Prior to joining MilliporeSigma, Kathy worked as an analytical chemist in the personal care products industry, and as a GC chemist and supervisor in the environmental testing industry. She is a member of the American Chemical Society, AOAC, and the Chromatography Forum of Delaware Valley.
                                                      Posters

                                                      POSTER SUBMISSION GUIDELINES

                                                      Virtual poster sessions offer the opportunity to present data to a global audience via a PDF poster and video summary, and discuss results with interested colleagues through email. Posters should be submitted as a PowerPoint file. Presentations should incorporate illustrative materials such as tables, graphs, photographs, and large-print text. This content is not peer reviewed. Submission is free.

                                                      SUBMIT YOUR ABSTRACT

                                                      Enter the following information to this Submission Form:

                                                      • Poster Title
                                                      • Your Name
                                                      • Your Institution
                                                      • Your Email
                                                      • Abstract describing the poster

                                                      All submitted abstracts will be reviewed and decisions regarding acceptance will be made as abstracts are received. You will be notified within one week of receipt about acceptance. Further details and registration materials will be provided at that time. You do not have to be present in order to have a poster displayed. Only those abstracts approved by LabRoots may display posters at this event.

                                                      If accepted, you will also have the opportunity to record a 3-5 minute summary video for each poster. LabRoots will work with each individual to create these videos. Video links and email contact information will be included on each poster displayed.

                                                      Questions? Email Posters@LabRoots.com

                                                      LabRoots Policy

                                                      Sponsored By

                                                      For information on becoming a sponsor or exhibitor, please click here.

                                                      testing


                                                      Committee

                                                      To download the Program Committee brochure here.

                                                      testing


                                                      • Kent Crowley

                                                        Kent Crowley, Pharm.D., is a board-certified Pharm.D. through the American Academy of Anti-Aging Medicine. He received his Doctor of Pharmacy from University of California, San Francisco and completed his residency with Kaiser Permanente in Los Angeles, CA. He completed his ...

                                                        See more See less
                                                      • Russ Cersosimo

                                                        Russell Cersosimo Jr. is the founder of Pittsburgh-based Miradati Technology, which is currently developing HIPAA-compliant, enterprise software that creates standardized data for medical cannabis research. Integrating both legacy and proprietary technologies, Miradati helps ...

                                                        See more See less
                                                      Help

                                                      General LabRoots Questions

                                                      For bugs, spam, technical support or questions please call +1-714-463-4673 or email support@labroots.com  
                                                      Contact us

                                                      Virtual Events and Webinars

                                                      Supported Configurations

                                                      • Operating System Internet Explorer Firefox Chrome Safari
                                                        Vista IE8+ FF10+ Chrome15+
                                                        Windows 7 IE8+ FF10+ Chrome15+
                                                        Windows 8 IE10 FF10+ Chrome15+
                                                        Mac OS X   FF10+ Chrome15+ Safari5.1+
                                                      • Cookie settings: session cookies enabled
                                                      • Browser configuration must have JavaScript enabled
                                                      • Adobe Flash player 10.2 or later

                                                      To watch our webinars and virtual events a modern browser such as Chrome, Firefox, Safari, or an updated version of Internet Explorer is required.

                                                      Internet Connection

                                                      • A minimum of 100Kbps is recommended for audio-only events
                                                      • A minimum of 300Kbps is recommended for speaker on-video events

                                                      Computer Equipment

                                                      • Screen Resolution: Minimum 1024x768
                                                      • Video Card: 65,000 colors minimum
                                                      • Sound card and speakers (or headphones) for hearing webcast in full format
                                                      • Audio Card: 16-bit minimum
                                                      • RAM: 512MB of free RAM

                                                      Firewall Protocol

                                                      • HTTP on port 80 or HTTPS on port 443
                                                      • Adobe RTMP on port 1935, 80, or 443 with automatic fall-back to RTMPT (RTMP tunneling) on ports 1935, 80 or 443
                                                      • RTMPE (RTMP encrypted) on ports 1935, 80 or 443

                                                      Work-At-Home Attendees

                                                      • If a corporate VPN is used, confirm that your network traffic is not directed over the company VPN. If it is, please turn off the VPN while attending the virtual event.

                                                      For A Seamless Experience

                                                      When using a mobile device, FREE Mobile Apps are available:

                                                      - For viewing Webinars:

                                                      - For viewing Virtual Events

                                                      Attendee Guide

                                                      • To learn more about how the virtual event works for attendees, download the Attendee Guide (PDF).

                                                      Virtual Event and Webinar Support:

                                                      Continuing Education (CME/CE) Support

                                                      Loading Comments...
                                                      Show Resources